High Tide is emerging as a cash-generative cannabis retail leader, with Q3 profitability, German medical-cannabis growth, and a 5.7x EV/EBITDA valuation supporting substantial upside despite execution and dilution risks.
Overview
High Tide Inc. is a Calgary-based, retail-focused cannabis company built around three segments: Canadian Canna Cabana stores, global e-commerce for accessories and hemp-derived CBD products, and German medical-cannabis distribution through Remexian Pharma. **The core advantage is a scaled discount-club ecosystem**: 232 corporate stores, more than 2.73 million Cabana Club members, over 186,000 paid ELITE members, and average store productivity of 1.8 to 2.2 times Canadian peers. The model has supported a 14% share in active Canadian provinces and same-store sales growth of 171% since the discount format launched in 2021. Q3 2026 revenue rose 33% year over year to $198.80 million CAD, adjusted EBITDA increased 53% to $16.20 million, and free cash flow rose 373% to $7.00 million. GAAP net income was $12.75 million CAD, while adjusted net income was $2.2 million. Remexian contributed $38.2 million CAD at a 26% gross margin. At $2.53 USD, the stock trades near 5.7x EV/EBITDA versus approximately 9.0x for peers. Near-term catalysts include positive free cash flow, expansion beyond 350 Canadian stores, German market growth, white-label penetration, and a technical move toward $3.00-$3.50 USD.